These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21198430)

  • 1. Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care.
    Kiertiburanakul S; Chotiprasitsakul D; Atamasirikul K; Sungkanuparph S
    Curr HIV Res; 2011 Jan; 9(1):54-60. PubMed ID: 21198430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in viral hepatitis B screening practices over time in West African HIV clinics.
    Coffie PA; Patassi A; Doumbia A; Bado G; Messou E; Minga A; Allah-Kouadio E; Zannou DM; Seydi M; Kakou AR; Dabis F; Wandeler G
    Med Mal Infect; 2017 Oct; 47(6):394-400. PubMed ID: 28545675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ; Zhang GM; Shen LP; Zheng H; Wang F; Miao N; Yuan QL; Sun XJ; Bi SL; Liang XF; Wang HQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):462-468. PubMed ID: 28592086
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America.
    Scott-Wright A; Hakre S; Bryan JP; Jaramillo R; Reyes LG; Cruess D; Macarthy PO; Gaydos JC
    Am J Trop Med Hyg; 1997 Mar; 56(3):285-90. PubMed ID: 9129530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Mandiouba NC; Thiam M; Diop F; Ndiaye O; Gueye SB; Seck SM; Dioura AA; Mbow M; Gaye-Diallo A; Mboup S; Touré-Kâne C
    J Med Virol; 2016 Mar; 88(3):461-5. PubMed ID: 26252424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand.
    Apidechkul T
    BMC Infect Dis; 2019 Feb; 19(1):125. PubMed ID: 30727952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil.
    Martins S; Livramento Ad; Andrigueti M; Kretzer IF; Machado MJ; Spada C; Treitinger A
    Rev Soc Bras Med Trop; 2014; 47(5):552-8. PubMed ID: 25467254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda.
    Makuza JD; Rwema JOT; Ntihabose CK; Dushimiyimana D; Umutesi J; Nisingizwe MP; Serumondo J; Semakula M; Riedel DJ; Nsanzimana S
    BMC Infect Dis; 2019 May; 19(1):381. PubMed ID: 31053097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients.
    Boyd A; Canini L; Gozlan J; Lascoux-Combe C; Miailhes P; Fonquernie L; Girard PM; Lacombe K
    J Clin Virol; 2017 Oct; 95():55-60. PubMed ID: 28869890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting.
    Sungkanuparph S; Wongprasit P; Manosuthi W; Atamasirikul K
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):863-6. PubMed ID: 19058581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
    Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.